Number of items: 57.
2020
Voysey, M. et al.
(2020)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Lancet,
(doi: 10.1016/S0140-6736(20)32661-1)
(Early Online Publication)
Gilbert, M. et al.
(2020)
Distemper, extinction and vaccination of the Amur tiger.
Proceedings of the National Academy of Sciences of the United States of America,
(doi: 10.1073/pnas.2000153117)
(PMID:33229566)
(PMCID:PMC7749280)
(Early Online Publication)
Volz, E. et al.
(2020)
Evaluating the effects of SARS-CoV-2 Spike mutation D614G on transmissibility and pathogenicity.
Cell,
(doi: 10.1016/j.cell.2020.11.020)
(PMID:33275900)
(PMCID:PMC7674007)
(Early Online Publication)
Sabir, S. R., Thomson, E. C. , Guzik, T. J., D’Acquisto, F. and Maffia, P.
(2020)
COVID-19: the new immune challenge.
Frontiers for Young Minds, 8,
582971.
(doi: 10.3389/frym.2020.582971)
Guzik, T. J. et al.
(2020)
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options.
Cardiovascular Research, 116(10),
pp. 1666-1687.
(doi: 10.1093/cvr/cvaa106)
(PMID:32352535)
(PMCID:PMC7197627)
Bradshaw, D. et al.
(2020)
Transmission of hepatitis C virus in HIV‐positive and PrEP‐using MSM in England.
Journal of Viral Hepatitis, 27(7),
pp. 721-730.
(doi: 10.1111/jvh.13286)
(PMID:32115809)
Mayanja, M. N., Mwiine, F. N., Kohl, A. , Thomson, E. C. and Lutwama, J. J.
(2020)
An update on the mosquito species composition and diversity in western and North Western Uganda.
Journal of Entomology and Zoology Studies, 8(2),
pp. 1074-1086.
Fawsitt, C. G. et al.
(2020)
Cost-effectiveness analysis of baseline testing for resistance-associated polymorphisms to optimize treatment outcome in genotype 1 noncirrhotic treatment-naïve patients with chronic hepatitis C virus.
Value in Health, 23(2),
pp. 180-190.
(doi: 10.1016/j.jval.2019.08.012)
(PMID:32113623)
(PMCID:PMC7057278)
2019
Bradshaw, D. et al.
(2019)
Consensus recommendations for resistance testing in the management of chronic hepatitis C virus infection: Public Health England HCV Resistance Group.
Journal of Infection, 79(6),
pp. 503-512.
(doi: 10.1016/j.jinf.2019.10.007)
(PMID:31629015)
Childs, K. et al.
(2019)
Suboptimal SVR rates in African patients with atypical Genotype 1 subtypes: implications for global elimination of Hepatitis C.
Journal of Hepatology, 71(6),
pp. 1099-1105.
(doi: 10.1016/j.jhep.2019.07.025)
(PMID:31400349)
Davis, C. et al.
(2019)
Postexposure prophylaxis with rVSV-ZEBOV following exposure to a patient with ebola virus disease relapse in the United Kingdom: an operational, safety, and immunogenicity report.
Clinical Infectious Diseases,
(doi: 10.1093/cid/ciz1165)
(PMID:31784751)
(Early Online Publication)
Davis, C. et al.
(2019)
Post-exposure prophylaxis with rVSV-ZEBOV following exposure to a patient with Ebola virus disease relapse in the UK: an operational, safety and immunogenicity report.
Clinical Infectious Diseases,
(doi: 10.1093/cid/ciz1165)
(PMID:31784751)
(Early Online Publication)
Baylis, S. A. et al.
(2019)
Development of a World Health Organization International Reference Panel for different genotypes of hepatitis E virus for nucleic acid amplification testing.
Journal of Clinical Virology, 119,
pp. 60-67.
(doi: 10.1016/j.jcv.2019.05.006)
(PMID:31431408)
Jerome, H. et al.
(2019)
Metagenomic next-generation sequencing aids the diagnosis of viral infections in febrile returning travellers.
Journal of Infection, 79(4),
pp. 383-388.
(doi: 10.1016/j.jinf.2019.08.003)
(PMID:31398374)
(PMCID:PMC6859916)
Ankcorn, M. et al.
(2019)
Convalescent plasma therapy for persistent hepatitis E virus infection.
Journal of Hepatology, 71(2),
pp. 434-438.
(doi: 10.1016/j.jhep.2019.04.008)
(PMID:31075322)
Fawsitt, C. G. et al.
(2019)
A cost-effectiveness analysis of shortened direct-acting antiviral treatment in genotype 1 noncirrhotic treatment-naive patients with chronic hepatitis C virus.
Value in Health, 22(6),
pp. 693-703.
(doi: 10.1016/j.jval.2018.12.011)
(PMID:31198187)
(PMCID:PMC6588649)
Singer, J. B. et al.
(2019)
Interpreting viral deep sequencing data with GLUE.
Viruses, 11(4),
323.
(doi: 10.3390/v11040323)
(PMID:30987147)
(PMCID:PMC6520954)
Davis, C. et al.
(2019)
New highly diverse hepatitis C strains detected in sub‐Saharan Africa have unknown susceptibility to direct‐acting antiviral treatments.
Hepatology, 69(4),
pp. 1426-1441.
(doi: 10.1002/hep.30342)
(PMID:30387174)
(PMCID:PMC6492010)
Ansari, M. A. et al.
(2019)
Interferon lambda 4 impacts the genetic diversity of hepatitis C virus.
eLife, 8,
e42463.
(doi: 10.7554/eLife.42463.001)
(PMID:31478835)
(PMCID:PMC6721795)
2018
Singer, J. B., Thomson, E. C. , McLauchlan, J. , Hughes, J. and Gifford, R. J.
(2018)
GLUE: a flexible software system for virus sequence data.
BMC Bioinformatics, 19,
532.
(doi: 10.1186/s12859-018-2459-9)
(PMID:30563445)
(PMCID:PMC6299651)
Mercuri, L., Thomson, E. C. , Hughes, J. and Karayiannis, P.
(2018)
Quasispecies changes with distinctive point mutations in the Hepatitis
C virus internal ribosome entry site (IRES) derived from PBMCs and plasma.
Advances in Virology, 2018,
4835252.
(doi: 10.1155/2018/4835252)
(PMID:30581467)
(PMCID:PMC6276526)
Thomson, E.
(2018)
HIV and HCV co-infection - Does it matter in the era of direct-acting antiviral therapies?
Microbiology Today, 45(4),
pp. 176-179.
da Silva Filipe, A. et al.
(2018)
Reply to: "Reply to: 'Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries'".
Journal of Hepatology, 68(4),
pp. 864-866.
(doi: 10.1016/j.jhep.2017.11.044)
(PMID:29339112)
2017
da Silva Filipe, A. et al.
(2017)
Response to DAA therapy in the NHS England early access programme for rare HCV subtypes from low and middle income countries.
Journal of Hepatology, 67(6),
pp. 1348-1350.
(doi: 10.1016/j.jhep.2017.06.035)
(PMID:28789880)
Niebel, M., Singer, J. B., Nickbakhsh, S. , Gifford, R. J. and Thomson, E. C.
(2017)
Hepatitis C and the absence of genomic data in low-income countries: a barrier on the road to elimination?
Lancet Gastroenterology and Hepatology, 2(10),
pp. 700-701.
(doi: 10.1016/S2468-1253(17)30257-1)
(PMID:28895545)
Shepherd, S. J., Black, H., Thomson, E. C. and Gunson, R. N.
(2017)
HIV positive patient with GBS-like syndrome.
JMM Case Reports, 4(8),
e005107.
(doi: 10.1099/jmmcr.0.005107)
(PMID:29026634)
(PMCID:PMC5610709)
Ansari, M. A. et al.
(2017)
Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus.
Nature Genetics, 49(5),
pp. 666-673.
(doi: 10.1038/ng.3835)
(PMID:28394351)
2016
Thomson, E. et al.
(2016)
Comparison of next generation sequencing technologies for the comprehensive assessment of full-length hepatitis C viral genomes.
Journal of Clinical Microbiology, 54(10),
pp. 2470-2484.
(doi: 10.1128/JCM.00330-16)
(PMID:27385709)
(PMCID:PMC5035407)
Jacobs, M. et al.
(2016)
Late Ebola virus relapse causing meningoencephalitis: a case report.
Lancet, 388(10043),
pp. 498-503.
(doi: 10.1016/S0140-6736(16)30386-5)
(PMID:27209148)
(PMCID:PMC4967715)
Martin, N. K. et al.
(2016)
Can HCV direct-acting antiviral treatment as prevention reverse the HCV epidemic amongst men who have sex with men in the UK - epidemiological and modelling insights.
Clinical Infectious Diseases, 62(9),
pp. 1072-1080.
(doi: 10.1093/cid/ciw075)
(PMID:26908813)
(PMCID:PMC4826456)
Swann, R. E. , Cowton, V. M., Robinson, M. W., Cole, S. J., Barclay, S. T., Mills, P. R., Thomson, E. C. , McLauchlan, J. and Patel, A.
(2016)
Broad anti-hepatitis C virus (HCV) antibody responses are associated with improved clinical disease parameters in chronic HCV infection.
Journal of Virology, 90(9),
pp. 4530-4543.
(doi: 10.1128/JVI.02669-15)
(PMID:26912610)
(PMCID:PMC4836347)
Robinson, M. W., Hughes, J. , Wilkie, G. S., Swann, R. , Barclay, S. T., Mills, P. R., Patel, A. H. , Thomson, E. C. and McLauchlan, J.
(2016)
Tracking TCRß sequence clonotype expansions during antiviral therapy using high-throughput sequencing of the hypervariable region.
Frontiers in Immunology, 7,
131.
(doi: 10.3389/fimmu.2016.00131)
(PMID:27092143)
(PMCID:PMC4820669)
Padam, P., Clark, S., Irving, W., Gellissen, R., Thomson, E. , Main, J. and Cooke, G.S.
(2016)
Reduced healthcare utilization following successful hepatitis C virus treatment in HIV-co-infected patients with mild liver disease.
Journal of Viral Hepatitis, 23(2),
pp. 123-129.
(doi: 10.1111/jvh.12484)
(PMID:26511293)
(PMCID:PMC4924594)
Martin, F., Lee, J., Thomson, E. , Tarrant, N., Hale, A. and Lacey, C. J.
(2016)
Two cases of possible transmitted drug resistant HIV virus: likely HIV superinfection and unmasking of pre-existing resistance.
International Journal of STD and AIDS, 27(1),
pp. 66-69.
(doi: 10.1177/0956462415571671)
(PMID:25663247)
(PMCID:PMC4674743)
2015
Jerome, H., Vattipally, S. B. and Thomson, E. C.
(2015)
Can we identify potential viral zoonoses before they cross the species barrier?
Microbiology Today, 42(4),
pp. 150-153.
Gaunt, E., Harvala, H., Osterback, R., Sreenu, V. B. , Thomson, E. , Waris, M. and Simmonds, P.
(2015)
Genetic characterization of human coxsackievirus A6 variants associated with atypical hand, foot and mouth disease: a potential role of recombination in emergence and pathogenicity.
Journal of General Virology, 96(5),
pp. 1067-1079.
(doi: 10.1099/vir.0.000062)
(PMID:25614593)
(PMCID:PMC4631059)
Abdelrahman, T., Hughes, J. , Main, J., McLauchlan, J. , Thursz, M. and Thomson, E.
(2015)
Reply.
Hepatology, 61(4),
p. 1438.
(doi: 10.1002/hep.27393)
(PMID:25147121)
(PMCID:PMC4407921)
Ardelrahman, T., Hughes, J. , Main, J., McLauchlan, J. , Thursz, M. and Thomson, E.
(2015)
Waiting time and transplantation for hepatocellular cancer: a balance between tempus fugit and carpe diem.
Hepatology, 61(4),
pp. 1438-1439.
(doi: 10.1002/hep.27434)
Shepherd, S. J., Abdelrahman, T., MacLean, A. R., Thomson, E. C. , Aitken, C. and Gunson, R. N.
(2015)
Prevalence of HCV NS3 pre-treatment resistance associated amino acid variants within a Scottish cohort.
Journal of Clinical Virology, 65,
pp. 50-53.
(doi: 10.1016/j.jcv.2015.02.005)
(PMID:25766988)
(PMCID:PMC4728298)
Abdelrahman, T., Hughes, J. , Main, J., McLauchlan, J. , Thursz, M. and Thomson, E.
(2015)
Next generation sequencing sheds light on the natural history of hepatitis C infection in patients that fail treatment.
Hepatology, 61(1),
pp. 88-97.
(doi: 10.1002/hep.27192)
(PMID:24797101)
(PMCID:PMC4303934)
2014
McNaughton, A.L., Thomson, E.C. , Templeton, K., Gunson, R.N. and McWilliam Leitch, E.C.
(2014)
Mixed genotype hepatitis C infections and implications for treatment.
Hepatology, 59(3),
p. 1209.
(doi: 10.1002/hep.26544)
(PMID:23744801)
(PMCID:PMC4296219)
2013
Leggewie, M., Sreenu, V. B. , Abdelrahman, T., Leitch, E. C., Wilkie, G., Klymenko, T., Muir, D., Thursz, M., Main, J. and Thomson, E.C.
(2013)
Natural NS3 resistance polymorphisms occur frequently prior to treatment in HIV-positive patients with acute hepatitis C.
AIDS, 27(15),
pp. 2485-2488.
(doi: 10.1097/QAD.0b013e328363b1f9)
(PMID:23770494)
2011
Thomson, E.C. , Smith, J.A. and Klenerman, P.
(2011)
The natural history of early hepatitis C virus evolution; lessons from a global outbreak in human immunodeficiency virus-1-infected individuals.
Journal of General Virology, 92(10),
pp. 2227-2236.
(doi: 10.1099/vir.0.033910-0)
Thomson, E.C. , Fleming, V.M., Main, J., Klenerman, P., Weber, J., Eliahoo, J., Smith, J., McClure, M.O. and Karayiannis, P.
(2011)
Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men.
Gut, 60(6),
pp. 837-845.
(doi: 10.1136/gut.2010.217166)
2010
Huang, K.-H.G. et al.
(2010)
B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection.
Nature Communications, 1,
p. 102.
(doi: 10.1038/ncomms1100)
Smith, J.A., Aberle, J.H., Fleming, V.M., Ferenci, P., Thomson, E.C. , Karayiannis, P., McLean, A.R., Holzmann, H. and Klenerman, P.
(2010)
Dynamic coinfection with multiple viral subtypes in acute hepatitis C.
Journal of Infectious Diseases, 202(12),
pp. 1770-1779.
(doi: 10.1086/657317)
Winston, A. et al.
(2010)
Does acute hepatitis C infection affect the central nervous system in HIV-1 infected individuals?
Journal of Viral Hepatitis, 17(6),
pp. 419-426.
(doi: 10.1111/j.1365-2893.2009.01198.x)
2009
Thomson, E.C. , Nastouli, E., Main, J., Karayiannis, P., Eliahoo, J., Muir, D. and McClure, M.O.
(2009)
Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV.
AIDS, 23(1),
pp. 89-93.
(doi: 10.1097/QAD.0b013e32831940a3)
Nastouli, E., Thomson, E.C. , Karayiannis, P., Main, J., McClure, M. and Muir, D.
(2009)
Diagnosing acute hepatitis C in HIV-infected patients: nucleic acid testing compared with antibody and antigen-antibody detecting methods.
Journal of Clinical Virology, 44(1),
pp. 78-80.
(doi: 10.1016/j.jcv.2008.09.008)
2008
Fox, J., Nastouli, E., Thomson, E.C. , Muir, D., McClure, M., Weber, J. and Fidler, S.
(2008)
Increasing incidence of acute hepatitis C in individuals diagnosed with primary HIV in the United Kingdom.
AIDS, 22(5),
pp. 666-668.
(doi: 10.1097/QAD.0b013e3282f5f4cf)
Thomson, E.C. and Main, J.
(2008)
Epidemiology of hepatitis C virus infection in HIV-infected individuals.
Journal of Viral Hepatitis, 15(11),
pp. 773-781.
(doi: 10.1111/j.1365-2893.2008.00981.x)
2007
Garvey, L., Thomson, E.C. , Main, J. and Winston, A.
(2007)
Response to "Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment".
JAIDS: Journal of Acquired Immune Deficiency Syndromes, 46(5),
pp. 656-657.
(doi: 10.1097/QAI.0b013e318157b0c8)
Garvey, L.J., Thomson, E.C. , Lloyd, J., Cooke, G.S., Goldin, R.D. and Main, J.
(2007)
Response to Mallet et al., 'Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients'.
AIDS, 21(11),
pp. 1494-1495.
(doi: 10.1097/QAD.0b013e3281e7ed64)
2006
Bloom, C., Thomson, E.C. and Main, J.
(2006)
An elderly lady with sudden blindness and a sore foot.
Journal of Infection, 52(2),
e53-e54.
(doi: 10.1016/j.jinf.2005.05.002)
Garvey, L., Thomson, E.C. and Taylor, G.P.
(2006)
Progressive multifocal leukoencephalopathy: prolonged survival in patients treated with protease inhibitors and cidofovir: a case series.
AIDS, 20(5),
pp. 791-793.
(doi: 10.1097/01.aids.0000216390.83351.87)
2004
Thomson, E.C. and Main, J.
(2004)
Advances in hepatitis B and C.
Current Opinion in Infectious Diseases, 17(5),
pp. 449-459.
2003
Thomson, E.C. and Lynn, W.A.
(2003)
Septic thrombophlebitis with multiple pulmonary abscesses.
Lancet Infectious Diseases, 3(2),
p. 86.
(doi: 10.1016/S1473-3099(03)00516-4)
This list was generated on Sun Jan 24 05:53:46 2021 GMT.